Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
D-Aspartate for Recovery from Brain Damage
NCT03228524Phase 1Unknown
- Sponsor
- Neuromed Pharmaceuticals
- Start
- Nov 2017
- Primary completion
- Jul 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of D-Aspartic Acid in traumatic brain injury (TBI) (2 arms), sponsored by Neuromed Pharmaceuticals. Primary endpoints: Barthel's Activities of Daily Living (ADL) up to 3 years, Functional Independence Measure up to 3 years and 8 more. Status: unknown.
02
Drugs
D-Aspartic Acid
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on NCT03228524.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03228524.